Known targets — ChEMBL curated mechanism
ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG
The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD2 | P14416 | 2/20 | 0.39 |
| ▸ | HTR1A | P08908 | 1/20 | 0.39 |
| ▸ | HTR2A | P28223 | 1/20 | 0.39 |
| ▸ | HTR7 | P34969 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | CA12 | O43570 | 1/20 | 0.37 |
| ▸ | CA2 | P00918 | 1/20 | 0.37 |
| ▸ | CA3 | P07451 | 1/20 | 0.37 |
| ▸ | CA4 | P22748 | 1/20 | 0.37 |
| ▸ | CA6 | P23280 | 1/20 | 0.37 |
| ▸ | CA5A | P35218 | 1/20 | 0.37 |
| ▸ | CA7 | P43166 | 1/20 | 0.37 |
| ▸ | CA9 | Q16790 | 1/20 | 0.37 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.37 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | PRMT3 | O60678 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL374859 | 0.97 | — | — | |
| Bromide SCHEMBL5432875 | 0.93 | DRD2 (0.39) | DRD2HTR1AHTR2AHTR7ALDH1A1 | |
| SCHEMBL17030310 | 0.79 | HTR1A (0.35) | DRD2HTR1AHTR2AHTR7ALDH1A1 | |
| SCHEMBL15182740 | 0.79 | CA12 (0.61) | DRD2HTR1AHTR2AHTR7ALDH1A1 | |
| SCHEMBL12890945 | 0.79 | CA12 (0.61) | DRD2HTR1AHTR2AHTR7ALDH1A1 | |
| SCHEMBL1697340 | 0.78 | ALDH1A1 (0.50) | DRD2HTR1AHTR2AHTR7ALDH1A1 | |
| SCHEMBL841236 | 0.76 | CA12 (0.39) | TSHRCA12CA2CA3CA4 | |
| SCHEMBL13270248 | 0.76 | DRD2 (0.41) | DRD2HTR1AHTR2AHTR7ALDH1A1 | |
| SCHEMBL8282658 | 0.75 | ALDH1A1 (0.56) | DRD2HTR1AHTR2AHTR7ALDH1A1 | |
| SCHEMBL23873076 | 0.73 | ALDH1A1 (0.61) | DRD2HTR1AHTR2AHTR7ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1477477-B1 | PROCESS FOR PREPARATION OF CAROTENOIDS | SUMITOMO CHEMICAL CO (JP) | 2010-12-22 | — | — | EP | disclosed |
| EP-1477477-A1 | PROCESS FOR PREPARATION OF CAROTENOIDS | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2004-11-17 | — | — | EP | disclosed |
| US-6806387-B2 | A STARTING MATERIAL FOR VITAMIN A DERIVATIVES AND VARIOUS TERPENE COMPOUNDS | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2004-10-19 | — | — | US | disclosed |
| US-20040204612-A1 | Process for preparation of carotenoids | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2004-10-14 | — | — | US | disclosed |
| EP-1199303-B1 | Process for producing retinol and intermediate compounds for producing the same | SUMITOMO CHEMICAL CO (JP) | 2004-09-22 | — | — | EP | disclosed |
| US-6784321-B2 | 1-((2-ARYLSULFONYL)(3-METHYL)(5-OXY)PENT-3-ENE)-2,6,6-TRIMETHY LCYCLOHEX-1-ENE DERIVATIVES | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2004-08-31 | — | — | US | disclosed |
| EP-1426357-A1 | PROCESS FOR PREPARATION OF ALLYL SULFONE DERIVATIVES AND INTERMEDIATES FOR THE PREPARATION | Sumitomo Chemical Company, Limited (JP) | 2004-06-09 | — | — | EP | disclosed |
| US-20040082814-A1 | Process for producing retinol and intermediate compounds for producing the same | SUMITOMO CHEMICAL COMPANY, LIMITED | 2004-04-29 | — | — | US | disclosed |
| US-20040054233-A1 | Process for preparation of allyl sulfone derivatives and intermediates for the preparation | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2004-03-18 | — | — | US | disclosed |
| US-20040034257-A1 | Novel sulfone derivatives and process for producing these | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2004-02-19 | — | — | US | disclosed |
| EP-1199303-A1 | Process for producing retinol and intermediate compounds for producing the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2002-04-24 | — | — | EP | disclosed |
| US-6348622-B1 | CHEMICAL INTERMEDIATES | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2002-02-19 | — | — | US | disclosed |
| US-6297402-B1 | CHEMICAL INTERMEDIATES FOR ASTAXANTHINE | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2001-10-02 | — | — | US | disclosed |
| US-20010025127-A1 | Dihalo-compound and process for producing vitamin A derivative | SUMITOMO CHEMICAL COMPANY, LTD. (JP) | 2001-09-27 | — | — | US | disclosed |
| EP-1120398-A2 | Dihalo-compound and process for producing vitamin A derivative | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2001-08-01 | — | — | EP | disclosed |
| US-6211411-B1 | SULFONE ALDEHYDE DERIVATIVES | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2001-04-03 | — | — | US | disclosed |
| US-6172265-B1 | DRUG; FOOD OR FEED ADJUVANT; CHEMICAL INTERMEDIATE FOR CANTHAXANTHIN | SUMITOMO CHEMICAL COMPANY LIMITED (JP) | 2001-01-09 | — | — | US | disclosed |
| US-6160181-A | Tetraene derivative and process for producing the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2000-12-12 | — | — | US | disclosed |
| EP-0983998-A1 | Tetraene derivative and process for producing the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2000-03-08 | — | — | EP | disclosed |
| EP-0900785-A2 | Vitamin A related compounds and process for producing the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1999-03-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040204612-A1 | Process for preparation of carotenoids | SCLY, RPS4Y1, ENY2 | DRD2 420/4885HTR1A 1798/4885HTR2A 1361/4885 |
| US-20040082814-A1 | Process for producing retinol and intermediate compounds for producing the same | ADH4, ADH1B, ADH7 | DRD2 258/4885HTR1A 701/4885HTR2A 1303/4885 |
| US-20040034257-A1 | Novel sulfone derivatives and process for producing these | RBP4, ADH4, RARB | DRD2 1459/4885HTR1A 4552/4885HTR2A 4060/4885 |
| US-20010025127-A1 | Dihalo-compound and process for producing vitamin A derivative | CYP2R1, CYP24A1, VDR | DRD2 442/4885HTR1A 703/4885HTR2A 994/4885 |
| US-20040054233-A1 | Process for preparation of allyl sulfone derivatives and intermediates for the preparation | ARSA, SULT1A1, SULT2A1 | DRD2 919/4885HTR1A 907/4885HTR2A 1010/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.